HOME ABOUT ▾ library contact order ABOUT NEUROAID ▸ CLINIcal studies ▸ safety profile ▸ Medical Professionals
composition & dosage ▸ Find out if neuroaid is right for you ABOUT NeuroAiD is an oral treatment helping victims of strokes and traumatic brain injuries who suffer from established deficits to recover their functional independence in addition to rehabilitation therapies and exercises. Moleac Highlights NeuroAiD Meta-Analysis at ASNA 2025 in Bali

???? ???????? | ????, ????????? | ? – ?? ?????? ????

Together with PT. Ferron Par Pharmaceuticals, Moleac was delighted to participate in the 16ᵗʰ Biennial Convention of the ASEAN Neurological Association (ASNA) 2025, held last week in Bali, Indonesia. This prestigious congress brought together neurologists and allied healthcare professionals, offering a rich program of presidential lectures, plenary symposiums, and parallel scientific sessions.

Dr. N. V. Ramani, Chair of the Asian Stroke Advisory Panel (ASAP), presented a poster on “Meta-Analysis of Effect of MLC601/MLC901 on Motor Recovery after Stroke”. The presentation summarized multiple clinical trials on NeuroAiD, reinforcing its role in post-stroke motor recovery and fostering valuable discussions with stroke care experts.

Moleac was proud to connect with the neurology community, exchange insights, and showcase our commitment to advancing neurological care in Southeast Asia and beyond.

To learn more about our work and commitment to neurological health, please visit www.moleac.com.